In 2014, Mallafre reported that signaling of glucose-dependent insulinotropic peptide (GIP) and its receptor (GIPR) played key roles in the pathogenesis of obesity and its associated insulin resistance. Here, GIPR is linked to obesity due to melanocortin 4 receptor deficiency.